ORGANIC
LETTERS
2007
Vol. 9, No. 10
2015-2017
Bioactive 2-Oxazolines: A New
Approach via One-Pot, Four-Component
Reaction
Lijun Fan, Emil Lobkovsky, and Bruce Ganem*
Department of Chemistry & Chemical Biology, Baker Laboratory, Cornell UniVersity,
Ithaca, New York 14853-1301
Received March 21, 2007
ABSTRACT
Substituted 2-oxazolines of the general structure shown above are found in several families of bioactive natural products and can be prepared
in an efficient and general one-pot, four-component condensation.
Oxazolines are widely used in polymer chemistry as synthetic
reagents and most recently as ligands in asymmetric syn-
thesis.1 Alkyl- and aryl-substituted 2-oxazolines are also
present in marine natural products2 and are important
pharmacophores in numerous bioactive natural products that
display cytotoxic, antitumor, neuroprotective, antibiotic, or
antifungal properties.
family of mammalian siderophores that utilize the 2-hydroxy-
phenyloxazoline carboxamide substructure (box) to sequester
iron in macrophages.5
We have been interested in developing convergent syn-
thetic routes to such complex oxazolines utilizing a multi-
component reaction (MCR) to assemble the key heterocyclic
pharmacophore in a single flask. Here, we report a powerful
and versatile 4-component condensation that efficiently
produces 2-substituted oxazoline-4-carboxamides and their
congeners as highlighted in 1-3 in good yields.
Some representative examples (Figure 1) include the
cytotoxic agent brasilibactin 1,3 a family of five antitumor
The approach we envisioned was based on the known
biosynthesis of many peptide-derived oxazolines, which
usually involves cyclization of N-acyl serine residues. We
initially considered an Ugi reaction using R-diazoketones
(readily prepared from acid chlorides using CH2N2) in place
of simple aldehydes or ketones. However, mixtures of
R-diazoketones, amines, isonitriles, and carboxylic acids
proved unreactive, even when heated to 60-70 °C.
(1) Review: Wong, G. S. K.; Wu, W. Chem. Heterocycl. Compd. 2004,
50, 331.
(2) Davidson, B. S. Chem. ReV. 1993, 93, 1771.
(3) Tsuda, M.; Yamakawa, M.; Oka, S.; Tanaka, Y.; Hoshino, Y.;
Mikami, Y.; Sato, A.; Fujiwara, H.; Ohizumi, Y.; Kobayashi, J. J. Nat.
Prod. 2005, 68, 462.
Figure 1. Substituted 2-oxazolines in bioactive natural products.
(4) Tsukamoto, M.; Murooka, K.; Nakajima, S.; Abe, S.; Suzuki, H.;
Hirano, K.; Kondo, H.; Kojiri, K.; Suda, H. J. Antibiot. 1997, 50, 815.
(5) Moody, D. B.; Young, D. C.; Cheng, T.-Y.; Rosat, J.-P.; Roura-mir,
C.; O’Connor, P. B.; Zajonc, D. M.; Walz, A.; Miller, M. J.; Levery, S. B.;
Wilson, I. A.; Costello, C. E.; Brenner, M. B. Science 2004, 303, 527.
substances represented by B32030A 2 and B32030B 3,4 and
the recently discovered T-cell antigen didehydroxymyco-
bactin 3, a complex lipopeptide related to the mycobactin
10.1021/ol070694h CCC: $37.00
© 2007 American Chemical Society
Published on Web 04/12/2007